Literature DB >> 10884027

Cytosolic 5'-nucleotidase hyperactivity in erythrocytes of Lesch-Nyhan syndrome patients.

R Pesi1, V Micheli, G Jacomelli, L Peruzzi, M Camici, M Garcia-Gil, S Allegrini, M G Tozzi.   

Abstract

Lesch-Nyhan syndrome is a metabolic-neurological syndrome caused by the X-linked deficiency of the purine salvage enzyme hypoxanthine-guanine phosphoribosyltransferase (HGPRT). Metabolic consequences of HGPRT deficiency have been clarified, but the connection with the neurological manifestations is still unknown. Much effort has been directed to finding other alterations in purine nucleotides in different cells of Lesch-Nyhan patients. A peculiar finding was the measure of appreciable amount of Z-nucleotides in red cells. We found significantly higher IMP-GMP-specific 5'-nucleotidase activity in the erythrocytes of seven patients with Lesch-Nyhan syndrome than in healthy controls. The same alteration was found in one individual with partial HGPRT deficiency displaying a severe neurological syndrome, and in two slightly hyperuricemic patients with a psychomotor delay. Since ZMP was a good substrate of 5'-nucleotidase producing Z-riboside, we incubated murine and human cultured neuronal cells with this nucleoside and found that it is toxic for our models, promoting apoptosis. This finding suggests an involvement of the toxicity of the Z-riboside in the pathogenesis of neurological disorders in Lesch-Nyhan syndrome and possibly in other pediatric neurological syndromes of uncertain origin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10884027     DOI: 10.1097/00001756-200006260-00006

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  12 in total

1.  Identification of the nucleotidase responsible for the AMP hydrolysing hyperactivity associated with neurological and developmental disorders.

Authors:  Rossana Pesi; Marcella Camici; Vanna Micheli; Laura Notarantonio; Gabriella Jacomelli; Maria Grazia Tozzi
Journal:  Neurochem Res       Date:  2007-07-06       Impact factor: 3.996

2.  5-Aminoimidazole-4-carboxamide riboside induces apoptosis in Jurkat cells, but the AMP-activated protein kinase is not involved.

Authors:  José M López; Antonio F Santidrián; Clara Campàs; Joan Gil
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

Review 3.  AMPK in the brain: its roles in energy balance and neuroprotection.

Authors:  Gabriele V Ronnett; Santosh Ramamurthy; Amy M Kleman; Leslie E Landree; Susan Aja
Journal:  J Neurochem       Date:  2009-05       Impact factor: 5.372

4.  NAD metabolism in HPRT-deficient mice.

Authors:  Vanna Micheli; Gabriella Jacomelli; Federica Di Marcello; Laura Notarantonio; Silvia Sestini; Barbara Cerboni; Matteo Bertelli; Giuseppe Pompucci; Hyder A Jinnah
Journal:  Metab Brain Dis       Date:  2009-03-25       Impact factor: 3.584

5.  Inborn errors of purine metabolism: clinical update and therapies.

Authors:  Shanti Balasubramaniam; John A Duley; John Christodoulou
Journal:  J Inherit Metab Dis       Date:  2014-06-28       Impact factor: 4.982

6.  Cortical spreading depression increases the phosphorylation of AMP-activated protein kinase in the cerebral cortex.

Authors:  Emanuela Viggiano; Davide Viggiano; Alessandro Viggiano; Bruno De Luca; Marcellino Monda
Journal:  Neurochem Res       Date:  2014-10-12       Impact factor: 3.996

Review 7.  Metabolic Aspects of Adenosine Functions in the Brain.

Authors:  Mercedes Garcia-Gil; Marcella Camici; Simone Allegrini; Rossana Pesi; Maria Grazia Tozzi
Journal:  Front Pharmacol       Date:  2021-05-14       Impact factor: 5.810

8.  Cytosolic 5'-nucleotidase II interacts with the leucin rich repeat of NLR family member Ipaf.

Authors:  Federico Cividini; Maria Grazia Tozzi; Alvaro Galli; Rossana Pesi; Marcella Camici; Charles Dumontet; Lars Petter Jordheim; Simone Allegrini
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

9.  Oligomeric interface modulation causes misregulation of purine 5´-nucleotidase in relapsed leukemia.

Authors:  Aleš Hnízda; Jana Škerlová; Milan Fábry; Petr Pachl; Martina Šinalová; Lukáš Vrzal; Petr Man; Petr Novák; Pavlína Řezáčová; Václav Veverka
Journal:  BMC Biol       Date:  2016-10-19       Impact factor: 7.431

Review 10.  Emerging Role of Purine Metabolizing Enzymes in Brain Function and Tumors.

Authors:  Mercedes Garcia-Gil; Marcella Camici; Simone Allegrini; Rossana Pesi; Edoardo Petrotto; Maria Grazia Tozzi
Journal:  Int J Mol Sci       Date:  2018-11-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.